26
|
Develoux M, Hennequin C, Le Loup G, Paris L, Magne D, Belkadi G, Pialoux G. Imported filariasis in Europe: A series of 31 cases from Metropolitan France. Eur J Intern Med 2017; 37:e37-e39. [PMID: 27733303 DOI: 10.1016/j.ejim.2016.09.021] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2016] [Revised: 09/21/2016] [Accepted: 09/26/2016] [Indexed: 10/20/2022]
|
27
|
Bellaud G, Canestri A, Gallah S, Merlant M, Cousseau S, Lebrette MG, Slama L, Pialoux G. Bacterial chondritis complications following ear piercing. Med Mal Infect 2016; 47:26-31. [PMID: 27596713 DOI: 10.1016/j.medmal.2016.07.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2016] [Accepted: 07/19/2016] [Indexed: 10/21/2022]
Abstract
BACKGROUND Body piercing has become widespread and is associated with increased complications. Post-piercing chondritis may lead to severe residual deformity. We aimed to report case patients presenting with post-piercing chondritis in our department and to describe clinical features and treatment. PATIENTS AND METHODS We conducted a retrospective study of patients presenting with post-piercing chondritis in the infectious disease department of Tenon Hospital, Paris, France. RESULTS We included 21 patients. Fifteen bacteriological cultures were positive (7 Pseudomonas aeruginosa, 5 Staphylococcus aureus, and three other). Dual intravenous antibiotic therapy was administered to 13 patients for a median duration of six days [2-8], replaced by an oral antibiotic therapy for a median duration of 15 days [7-40]. Eight patients received oral antibiotic monotherapy for 10 days [7-30]. Median duration of antibiotic therapy was 16 days. Earring removal was performed for 18 patients. No ear deformity or general complication was reported. CONCLUSION Transcartilaginous ear piercing may lead to infectious complications or deformity. In case of chondritis, early administration of an antibiotic therapy active against P. aeruginosa and S. aureus is recommended. Specific guidelines are needed.
Collapse
|
28
|
Massari V, Chauvin P, Reydellet N, Jauffret-Roustide M, Rouzioux C, Pialoux G. Premiers résultats de l’étude ANRS-CUBE : triple dépistage VIH-VHB-VHC par tests rapides à Paris. Rev Epidemiol Sante Publique 2016. [DOI: 10.1016/j.respe.2016.06.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
29
|
Chas J, Lebrette M, Amiel C, Lassel L, Adda A, Guessant S, Chevaliez S, Peytavin G, Pialoux G. COL 4-02 - Efficience d’une prise en charge intégrée des nouveaux traitements du VHC. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30272-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
30
|
Bellaud G, Canestri A, Collarino R, Lassel L, Pialoux G. NEURO-04 - Méningites à entérovirus de l’adulte : expérience d’un centre parisien. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30468-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
31
|
Bellaud G, Merlant M, Gallah S, Lebrette M, Canestri A, Pialoux G. Chondrites bactériennes de l’oreille liées au piercing : à propos d’une série de 10 cas. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.423] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
32
|
Despiégel N, Marcellin AG, Aubin C, Espinas C, Laurisse A, Pialoux G. Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France. VALUE IN HEALTH : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH 2014; 17:A678-A679. [PMID: 27202502 DOI: 10.1016/j.jval.2014.08.2526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|
33
|
Reynes J, Pialoux G, Girard PM, Cotte L, Pellegrin JL, Ebrahimi R, Nguyen T. COL09-03: Simplification par elvitégravir/cobicistat/emtricitabine/ténofovir DF (E/C/F/TDF) d’une trithérapie antirétrovirale avec inhibiteur de protéase (IP) boosté : efficacité et tolérance. Med Mal Infect 2014. [DOI: 10.1016/s0399-077x(14)70081-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
34
|
Yazdanpanah Y, Khuong-Josses MA, Hocqueloux L, Pialoux G, Durant J, Wynne B, Granier C, Tebas P, Pappa K, Min S. 48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial. BMC Infect Dis 2014. [PMCID: PMC4221003 DOI: 10.1186/1471-2334-14-s2-p72] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
35
|
Ruppé E, Armand-Lefèvre L, Estellat C, El-Mniai A, Boussadia Y, Consigny PH, Girard PM, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farèse M, Coignard B, Lucet JC, Andremont A, Matheron S. Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. ACTA ACUST UNITED AC 2014; 19. [PMID: 24739981 DOI: 10.2807/1560-7917.es2014.19.14.20768] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Healthy travellers to countries where carbapenemases-producing Enterobacteriaceae (CPE) are endemic might be at risk for their acquisition, even without contact with the local healthcare system. Here, we report the acquisition of CPE (two OXA-181, one New Delhi metallo-beta-lactamase 1 (NDM-1)) in three healthy travellers returning from India. The duration of CPE intestinal carriage was less than one month. The results indicate that healthy travellers recently returning from India might be considered as at risk for CPE carriage.
Collapse
|
36
|
Katlama C, Assoumou L, Valantin MA, Soulie C, Duvivier C, Chablais L, Kolta S, Pialoux G, Mercie P, Simon A, Costagliola D, Peytavin G, Marcelin AG, Katlama C, Simon A, Valantin MA, Assoumou L, Costagliola D, Soulie C, Calvez V, Marcelin AG, Peytavin G, Katlama C, Simon A, Valantin MA, Assoumou L, Costagliola D, Chablais L, Peytavin G, Capeau J, Bastard JP, Kolta S, Soulie C, Calvez V, Marcelin AG, Couffin Cadiergues S, Saillard J, Rey-Coquais X, Durand F, Lemarchand C, Cuzin L, Aboulker JP, Fisher H. Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study. J Antimicrob Chemother 2014; 69:1648-52. [DOI: 10.1093/jac/dkt536] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
37
|
Bani-Sadr F, Chakvetadze C, Galperine T, Lassel L, Bonnard P, Lependeven C, Roque-Afonso AM, Pialoux G. Biphasic hepatitis A with severe cholestasis and thrombocytopenic purpura in an HIV-1-infected male patient. Med Mal Infect 2014; 44:81-2. [DOI: 10.1016/j.medmal.2013.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2013] [Revised: 11/18/2013] [Accepted: 12/03/2013] [Indexed: 11/30/2022]
|
38
|
Héma A, Lescure F, Fontaine C, Felhahi S, Bastard J, Drabo J, Sawadogo A, Pialoux G, Plaisier E. Prévalence et facteurs de risque de maladie rénale chronique au cours de l’infection VIH au Burkina Faso. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
39
|
Belkadi G, Buot G, Senghor Y, Guitard J, Develoux M, Magne D, Cartes G, Callard P, Lassel L, Pialoux G, Roux P, Hennequin C. [Comment on this case report]. J Mycol Med 2013; 22:206-9. [PMID: 23631014 DOI: 10.1016/j.mycmed.2012.04.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
Saadoun D, Resche Rigon M, Thibault V, Longuet M, Pol S, Blanc F, Pialoux G, Karras A, Bazin-Karra D, Cazorla C, Vittecoq D, Musset L, Decaux O, Ziza JM, Lambotte O, Cacoub P. Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Ann Rheum Dis 2013; 73:831-7. [PMID: 23606708 PMCID: PMC3995244 DOI: 10.1136/annrheumdis-2012-202770] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Background The standard-of-care treatment of patients with hepatitis C virus (HCV)-mixed cryoglobulinemia (MC) vasculitis includes pegylated interferon α (PegIFN)-α plus ribavirin and/or rituximab. About 30–40% of patients are non-responders or relapsers to such combination. Objective To analyse the safety and efficacy of Peg-IFNα/ribavirin/protease inhibitor combination in HCV-MC vasculitis. Patients and methods Open-label, prospective, cohort study including 23 patients with HCV-MC vasculitis. Peg-IFNα/ribavirin was associated to telaprevir (375 mg three times daily, for 12 weeks, (n=15)) or boceprevir (800 mg three times daily, for 44 weeks, (n=8)) for 48 weeks. Results The median age was 59 (52.5–66) years, with 48.8% women. Thirteen patients (56.5%) were complete clinical responders, and 10 (43.5%) were partial responders at week 24. The virological response (ie, HCV RNA negativation) was of 69.6% at week 24 (p=0.005). The cryoglobulin level decreased from 0.44 to 0.06 g/l (p=0.0006) and the C4 level increased from 0.09 to 0.15 g/l (p=0.045). Grades 3 and 4 adverse events (mainly anaemia, neutropenia and thrombocytopenia) were observed in 10 cases (43.5%). Twenty patients (87%) received erythropoietin, 9 (39.1%) had red cell transfusion, and 2 (8.7%) had granulocyte stimulating agents. Antiviral therapy discontinuation was required in 8 (34.7%) patients for virological non-response (n=5), virological relapse (n=2) and depression (n=1). Conclusions Peg-IFNα/ribavirin/protease inhibitor combination seems highly effective in HCV-MC. Such therapeutic regimen should be administered cautiously considering the high rate of side effects.
Collapse
|
41
|
Thibault J, Cordel H, Vimont S, Verdet C, Denis M, Pialoux G, Arlet G, Debrix I, Guessant S. CPC-067 Impact of a Multidisciplinary Team on the Proper Use of Carbapenems: Before/After Survey at Tenon Hospital. Eur J Hosp Pharm 2013. [DOI: 10.1136/ejhpharm-2013-000276.524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
42
|
Saadoun D, Thibault V, Pol S, Blanc F, Pialoux G, Karras A, Bazin-Karra D, Vittecoq D, Decaux O, Ziza JM, Lambotte O, Cacoub P. Efficacité et tolérance de la trithérapie antivirale (Peg-IFN alpha/ribavirine/inhibiteur de protéase) chez des patients présentant une vascularite cryoglobulinémique associée au VHC : résultats à 24 semaines. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
43
|
Belkadi G, Buot G, Senghor Y, Guitard J, Develoux M, Magne D, Carles G, Callard P, Lassel L, Pialoux G, Roux P, Hennequin C. Réponses à « Commentez ce cas clinique ». J Mycol Med 2012. [DOI: 10.1016/j.mycmed.2012.04.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
44
|
Federspiel F, Coleou J, Adda A, Traore K, Slama L, Debrix I, Pialoux G, Guessant S. Patient education for HIV-infected patients: a tool for success. Eur J Hosp Pharm 2012. [DOI: 10.1136/ejhpharm-2012-000074.455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
45
|
Ghania B, Yaye S, Lassel L, Buot G, Develoux M, Guitard J, Menessier C, Carles G, Callard P, Pialoux G, Roux P, Hennequin C. Penicilliose à penicillium marneffei chez une patiente immunodéprimé non VIH. J Mycol Med 2012. [DOI: 10.1016/j.mycmed.2011.12.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
46
|
Develoux M, Le Loup G, Dautheville S, Belkadi G, Magne D, Lassel L, Bonnard P, Pialoux G. [Malaria among immigrants, experience of a Parisian hospital (2006-2010)]. ACTA ACUST UNITED AC 2012; 105:95-102. [PMID: 22328065 DOI: 10.1007/s13149-012-0217-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2011] [Accepted: 11/29/2011] [Indexed: 10/28/2022]
Abstract
In recent days immigrants represent the main risk group for imported malaria in northern countries. Most of them are migrants returning to their country of origin to visit friends and relatives (VFR). We retrospectively examined the main clinical, biological, and therapeutic data of all malaria cases in immigrants from 2006 to 2010 in Tenon hospital, Paris. The hospital is situated in a Paris district with an important African community. During the study period 239 imported malaria cases were observed in adults of which 199 were immigrants, 186 VFR, and 13 recently arrived. Most cases were from sub-Saharan Africa and Comoro islands. Chimioprophylaxis was not taken in 81.2% of VFR. It was inadequate in 43.7% and not taken correctly in 84.4%. Plasmodium falciparum was the most frequent species identified: 190/199 (95.5%). Severe P. falciparum malaria was observed in 25 cases (13.2%); two of them were recently arrived. One patient, African VFR, died. In this series two high-risk groups were represented: HIV-infected patients and pregnant women. Six of the HIV patients had severe malaria and all pregnant women had anemia. Our results are similar to those observed recently in other European countries. Mean age of VFR is increasing and the risk for severe P. falciparum malaria became identical to the one observed in non-immune travelers. Protection measures remain still insufficient in this population of travelers.
Collapse
|
47
|
Bonnard P, Pialoux G. Evaluation of a computer algorithm for promoting both annual hepatitis C screening and hepatitis B vaccination among HIV-infected individuals (ORCHESTRA programme). Int J STD AIDS 2012; 22:613. [PMID: 21998187 DOI: 10.1258/ijsa.2011.011192] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
48
|
Zaidan M, Dettwiller S, Lescure X, Pacanowski J, Brochériou I, Rougier J, Rondeau E, Pialoux G, Girard P, Ronco P, Plaisier E. Néphropathies tubulo-interstitielles chez les patients infectés par le VIH. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
49
|
Stankovic Stojanovic K, Lionnet F, Girot R, Lescure F, Pialoux G, Le Loup G. The risk of going abroad in sickle cell disease: a study of 148 adults. Trans R Soc Trop Med Hyg 2011; 105:310-4. [DOI: 10.1016/j.trstmh.2011.02.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2010] [Revised: 02/16/2011] [Accepted: 02/16/2011] [Indexed: 11/30/2022] Open
|
50
|
Bommenel T, Launay O, Meynard JL, Gilquin J, Katlama C, Lascaux AS, Mahamat A, Martinez V, Pradier C, Rouveix E, Simon A, Costagliola D, Abgrall S, Abgrall S, Barin F, Bentata M, Billaud E, Boue F, Burty C, Cabie A, Costagliola D, Cotte L, de Truchis P, Duval X, Duvivier C, Enel P, Gasnault J, Gaud C, Gilquin J, Grabar S, Katlama C, Khuong MA, Lang JM, Lascaux AS, Launay O, Mahamat A, Mary-Krause M, Matheron S, Meynard JL, Pavie J, Pialoux G, Pilorge F, Poizot-Martin I, Pradier C, Reynes J, Rouveix E, Simon A, Tattevin P, Tissot-Dupont H, Viard JP, Viget N, Brosseau M, Salomon V, Jacquemet N, Guiguet M, Lanoy E, Lievre L, Selinger-Leneman H, Lacombe JM, Potard V, Bricaire F, Herson S, Desplanque N, Girard PM, Meyohas MC, Picard O, Cadranel J, Mayaud C, Clauvel JP, Decazes JM, Gerard L, Molina JM, Diemer M, Sellier P, Honore P, Jeantils V, Tassi S, Mechali D, Taverne B, Bouvet E, Crickx B, Ecobichon JL, Picard-Dahan C, Yeni P, Berthe H, Dupont C, Chandemerle C, Mortier E, Tisne-Dessus D, Weiss L, Salmon D, Auperin I, Roudiere L, Fior R, Delfraissy JF, Goujard C, Jung C, Lesprit P, Vittecoq D, Fraisse P, Rey D, Beck-Wirth G, Stahl JP, Lecercq P, Gourdon F, Laurichesse H, Fresard A, Lucht F, Bazin C, Verdon R, Chavanet P, Arvieux C, Michelet C, Choutet P, Goudeau A, Maitre MF, Hoen B, Elinger P, Faller JP, Borsa-Lebas F, Caron F, Daures JP, May T, Rabaud C, Berger JL, Remy G, Arlet-Suau E, Cuzin L, Massip P, Thiercelin Legrand MF, Pontonnier G, Yasdanpanah Y, Dellamonica P, Pugliese P, Aleksandrowicz K, Quinsat D, Ravaux I, Delmont JP, Moreau J, Gastaut JA, Retornaz F, Soubeyrand J, Galinier A, Ruiz JM, Allegre T, Blanc PA, Bonnet-Montchardon D, Lepeu G, Granet-Brunello P, Esterni JP, Pelissier L, Cohen-Valensi R, Nezri M, Chapadaud S, Laffeuillade A, Raffi F, Boibieux A, Peyramond D, Livrozet JM, Touraine JL, Trepo C, Strobel M, Bissuel F, Pradinaud R, Sobesky M, Contant M. Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir. J Antimicrob Chemother 2011; 66:1869-77. [DOI: 10.1093/jac/dkr208] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|